The intraoperative use of internal iliac artery balloon catheters in cesarean deliveries for abnormal invasive placentation: A 3-year retrospective cohort review in Doha, Qatar.

cesarean section internal iliac artery balloon occlusion catheter operative hemorrhage placenta accreta spectrum

Journal

Qatar medical journal
ISSN: 0253-8253
Titre abrégé: Qatar Med J
Pays: Qatar
ID NLM: 8101648

Informations de publication

Date de publication:
2021
Historique:
received: 29 06 2020
accepted: 07 09 2020
entrez: 8 4 2021
pubmed: 9 4 2021
medline: 9 4 2021
Statut: epublish

Résumé

Abnormal invasive placentation leads to massive intraoperative hemorrhage and maternal morbidity. This study aimed to assess the impact of the preoperative use of internal iliac artery balloon occlusion (IIABO) catheters in patients who had a cesarean delivery (CD) for invasive placentation, commonly known as the placenta accreta spectrum. This retrospective cohort study reviewed 67 pregnancies complicated by abnormal invasive placenta and confirmed intraoperatively. Preoperative planned placement of IIABO was performed in 33 women who underwent elective CD. Senior Obstetricians with the necessary expertise performed all CDs. The primary outcome measures were: intraoperative blood loss, blood transfusion requirement, duration of surgery and the need for hemostatic measures. Univariate comparison between the groups and regression analysis of the primary outcome and controlling for confounders, were performed. No statistically significant difference was observed between the groups with intraoperative hemorrhage volume of above 3000 mL (unadjusted odds ratio [OR] 0.94 [no-IIABO group as the reference]; The placement of IIABO catheters is an invasive procedure, which consumes time and resources. Its value as a means of reducing intraoperative blood loss or preserving the uterus in patients with abnormal placental adherence appears questionable. In this cohort study, there was no statistical difference in blood loss, and the need for other steps to control hemorrhage between women with and without IIABO catheters.

Sections du résumé

BACKGROUND BACKGROUND
Abnormal invasive placentation leads to massive intraoperative hemorrhage and maternal morbidity. This study aimed to assess the impact of the preoperative use of internal iliac artery balloon occlusion (IIABO) catheters in patients who had a cesarean delivery (CD) for invasive placentation, commonly known as the placenta accreta spectrum.
METHODS METHODS
This retrospective cohort study reviewed 67 pregnancies complicated by abnormal invasive placenta and confirmed intraoperatively. Preoperative planned placement of IIABO was performed in 33 women who underwent elective CD. Senior Obstetricians with the necessary expertise performed all CDs. The primary outcome measures were: intraoperative blood loss, blood transfusion requirement, duration of surgery and the need for hemostatic measures. Univariate comparison between the groups and regression analysis of the primary outcome and controlling for confounders, were performed.
RESULTS RESULTS
No statistically significant difference was observed between the groups with intraoperative hemorrhage volume of above 3000 mL (unadjusted odds ratio [OR] 0.94 [no-IIABO group as the reference];
CONCLUSIONS CONCLUSIONS
The placement of IIABO catheters is an invasive procedure, which consumes time and resources. Its value as a means of reducing intraoperative blood loss or preserving the uterus in patients with abnormal placental adherence appears questionable. In this cohort study, there was no statistical difference in blood loss, and the need for other steps to control hemorrhage between women with and without IIABO catheters.

Identifiants

pubmed: 33828954
doi: 10.5339/qmj.2021.8
pii: qmj.2021.8
pmc: PMC7961153
doi:

Types de publication

Journal Article

Langues

eng

Pagination

8

Informations de copyright

© 2021 Ahmed, Minisha, Babarinsa, Omar, Bayo, Omar, Farrell, licensee HBKU Press.

Références

Obstet Gynecol. 2012 Jul;120(1):207-11
pubmed: 22914422
Diagn Interv Radiol. 2017 May-Jun;23(3):173-179
pubmed: 28345524
Am J Obstet Gynecol. 2011 Sep;205(3):262.e1-8
pubmed: 22071057
Arch Gynecol Obstet. 2015 May;291(5):993-8
pubmed: 25288269
J Neonatal Perinatal Med. 2015;8(4):293-6
pubmed: 26836817
Can Assoc Radiol J. 2015 May;66(2):179-84
pubmed: 25797171
BJOG. 2019 Jan;126(1):e1-e48
pubmed: 30260097
J Vasc Interv Radiol. 2011 Feb;22(2):169-76
pubmed: 21183360
Obstet Gynecol Surv. 2012 Aug;67(8):503-19
pubmed: 22926275
Clinics (Sao Paulo). 2019;74:e946
pubmed: 31241664
BMC Anesthesiol. 2020 May 30;20(1):133
pubmed: 32473651
Obstet Gynecol Sci. 2017 Jan;60(1):18-25
pubmed: 28217667
Int J Obstet Anesth. 2011 Jan;20(1):70-3
pubmed: 21168325
Am J Case Rep. 2013 Oct 11;14:409-11
pubmed: 24147189
JA Clin Rep. 2019 Feb 12;5(1):9
pubmed: 32026036
Am J Obstet Gynecol. 2018 Dec;219(6):B2-B16
pubmed: 30471891
BMC Pregnancy Childbirth. 2019 Jan 15;19(1):30
pubmed: 30646863
Am J Obstet Gynecol. 2020 Jul;223(1):117.e1-117.e13
pubmed: 31978436
Placenta. 2012 Apr;33(4):244-51
pubmed: 22284667
Medicine (Baltimore). 2017 Nov;96(45):e8276
pubmed: 29137011
Anaesthesia. 2017 Jul;72(7):853-858
pubmed: 28401537
Int J Gynaecol Obstet. 2018 Mar;140(3):291-298
pubmed: 29405320
J Obstet Gynaecol Can. 2019 Apr;41(4):466-472
pubmed: 30885297

Auteurs

Husham A Ahmed (HA)

Department of Obstetrics and Gynecology, Women's Wellness and Research Center, Hamad Medical Corporation, PO Box 3050, Doha-Qatar E-mail: IBabarinsa@hamad.qa.

Fathima Minisha (F)

Department of Obstetrics and Gynecology, Women's Wellness and Research Center, Hamad Medical Corporation, PO Box 3050, Doha-Qatar E-mail: IBabarinsa@hamad.qa.

Isaac A Babarinsa (IA)

Department of Obstetrics and Gynecology, Women's Wellness and Research Center, Hamad Medical Corporation, PO Box 3050, Doha-Qatar E-mail: IBabarinsa@hamad.qa.

Ahmed J Omar (AJ)

Interventional Radiology Department, Hamad Medical Corporation, PO Box 3050, Doha-Qatar.

Arabo I Bayo (AI)

Department of Obstetrics and Gynecology, Women's Wellness and Research Center, Hamad Medical Corporation, PO Box 3050, Doha-Qatar E-mail: IBabarinsa@hamad.qa.

Khalid K Omar (KK)

Department of Obstetrics and Gynecology, Women's Wellness and Research Center, Hamad Medical Corporation, PO Box 3050, Doha-Qatar E-mail: IBabarinsa@hamad.qa.

Thomas A Farrell (TA)

Department of Obstetrics and Gynecology, Women's Wellness and Research Center, Hamad Medical Corporation, PO Box 3050, Doha-Qatar E-mail: IBabarinsa@hamad.qa.

Classifications MeSH